Tracking serous endometrial intraepithelial carcinoma
Part of Cancer, Women’s health & pregnancy clinical trials.
This study follows women diagnosed with a very early form of uterine cancer called serous endometrial intraepithelial carcinoma (SEIC). The goal is to collect information about the condition and its outcomes. You may be able to join if you have SEIC and are 18 or older.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with serous endometrial intraepithelial carcinoma (SEIC).
- You are 18 years old or older.
- You can read and write in Dutch or English.
- You do not have any other type of uterine cancer or invasive cancer.
- You have not had treatment for another cancer in the last 2 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at combining genetic testing with surgical exams to better understand endometrial cancer. It may help doctors see which treatments could work best for you.
This study uses advanced genetic testing (next-generation sequencing) to look at the molecular makeup of endometrial cancer or its rare subtype, carcinosarcoma. The goal is to better understand the cancer and possibly guide more personalized treatment.
This study looks for “methylated DNA markers” (special DNA patterns) to help detect endometrial, ovarian, and cervical cancers, and to support doctors around planned procedures. It may help find cancer earlier or better sort out who needs closer treatment.
This trial studies tumor DNA in blood and tissue from people with aggressive endometrial cancer to better understand the disease. You donate samples during surgery and follow-up visits.
This study is testing a blood test called Signatera to see if it can find leftover cancer DNA after treatment for early-stage endometrial cancer. It may help doctors decide who needs more treatment and who can safely be watched.
This study uses two simple tests (a cell sample from the uterus and a cervical DNA test) to find endometrial cancer early and to check how well fertility-sparing treatment is working.
Hear when a new Serous Endometrial Intraepithalial Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.